The results demonstrated that, compared to the HC cohorts, the proportions of CD8+ TEM, CD8+ TEFF, and MAIT cells were significantly reduced in the B-ALL cohorts (p < 0.05) (Figure 3C). The gene discussed is CD8A; the disease is precursor B-cell acute lymphoblastic leukemia.